Vertus Energy Secures €8.75M Seed Funding to Revolutionize Waste-to-X Biotech Solutions

Vertus Energy, a pioneering industrial biotech firm specializing in Waste-to-X solutions, has successfully raised €8.75 million in a Seed funding round to advance its innovative approach to managing bacteria behavior in biogas production. This funding marks a significant milestone for Vertus Energy as it strives to redefine waste treatment by converting it into valuable resources…

Read More

IdentifAI Secures €2.2M to Combat Deepfake Threats with Advanced Detection Models

Milan-based IdentifAI, a pioneering startup focused on identifying and mitigating deepfake content through cutting-edge technology, has announced a successful seed funding round, raising €2.2 million. This significant investment will fuel the company’s mission to develop sophisticated generative models that distinguish between human-created and AI-generated content. The funding round, led by United Ventures, a venture capital…

Read More

HubiFi Raises $2.5 Million in Seed Funding to Transform Revenue Management for High-Transaction Enterprises

HubiFi, a cutting-edge solution in financial intelligence and revenue recognition, has successfully completed its seed funding round with $2.5 million secured. This investment, co-led by Motivate Ventures, Anthemis (with support from Foxe Capital), and Rev1, marks a pivotal step in advancing HubiFi’s mission to revolutionize revenue management for high-transaction businesses. HubiFi, launched in 2023, addresses…

Read More

Create Wellness Secures $5 Million in Series A Funding to Propel Expansion of Creatine-Based Innovations

Create Wellness, Inc., a trailblazer in the health and wellness sector, has successfully raised $5 million in Series A funding, spearheaded by Unilever Ventures. This latest investment boosts Create Wellness’ total funding to $7.3 million. The funds will be instrumental in advancing the company’s mission to broaden access to its pioneering creatine-based products. Founded by…

Read More

Certify Locks in $40M to Lead the Future of Provider Data Intelligence in Healthcare

Certify, a pioneer in provider data intelligence, has secured $40 million in a Series B funding round led by Transformation Capital, with continued investment from General Catalyst, Upfront Ventures, and new funding from SemperVirens. This infusion brings Certify’s total capital raised to $69 million and follows a remarkable triple-year growth trajectory. Founded and led by…

Read More

Altana Secures $200M in Series C Funding to Transform Global Value Chain Management

Altana, the trailblazer in Value Chain Management Systems, has successfully closed a $200 million Series C funding round. Led by Thomas Tull’s US Innovative Technology Fund (USIT), this round also saw contributions from March Capital, Generation Investment Management, Salesforce Ventures, Friends and Family Capital, and Altana’s key existing investors, including GV (Google Ventures), Activate Capital,…

Read More

Constellation Technologies & Operations Secures €9.3M to Revolutionize Satellite Internet Access

In a significant development for the telecommunications sector, Constellation Technologies & Operations has successfully raised €9.3 million in funding to support its ambitious plan for satellite internet connectivity. Founded in 2022 by Charles Delfieux, the startup is on a mission to enable telecom operators to provide high-speed, low-latency internet from space, with a focus on…

Read More

With a $60 Million Credit Raise, Tensec Bets on AI to Redraw the Map of Cross-Border Finance for Global Trading Firms

In a decisive move for the cross‑border payments landscape, Tensec, the San Francisco‑based fintech building AI‑native B2B financial infrastructure, has secured a $60 million credit facility from Upper90 Capital Management, LP (“Upper90”). This infusion is set to propel the startup from processing roughly $500 million in annual trade volume to an ambitious target of $5 billion—a ten‑fold leap aimed…

Read More
Morphocell Technologies

A US$50M Raise Positions Morphocell Technologies at the Center of Regenerative Medicine’s Next Phase

In an industry where clinical timelines stretch a decade and financing cycles can make or break scientific ambition, Morphocell Technologies has pulled off a milestone that places it among Canada’s most serious regenerative-medicine contenders. The Montreal-based biotechnology company has completed its full US$50 million Series A raise, adding a fresh US$10 million extension round led…

Read More
CEO Benny Sørensen, MD, PhD,

Hemab Therapeutics Raises $157 Million to Transform the Future of Rare Bleeding Disorder Care

For a biotech world often focused on oncology and gene editing, Hemab Therapeutics has carved out a very different frontier: rare, inherited bleeding disorders that have long gone overlooked. The company has raised $157 million in a Series C round, a multifold oversubscribed financing led by Sofinnova Partners, with participation from a global sovereign wealth…

Read More